Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis

Clinical and Experimental Immunology
S HashimotoT Horie

Abstract

MCP-1 and MIP-1alpha exhibit chemotactic activity toward macrophages/monocytes and induce the production of inflammatory cytokines affecting granuloma formation. Up-regulated expression of MCP-1 and MIP-1alpha in the affected organ of sarcoidosis has been shown; however, the relationship between their plasma levels and the clinical course of this disease has not been determined. In the present study we measured plasma MCP-1 and MIP-1alpha levels in 26 patients with active sarcoidosis by ELISA in order to assess the state of MCP-1 and MIP-1alpha in this disease. Most patients in this study (21/26) had clinical evidence of extrathoracic disease in addition to pulmonary involvement. In addition, a high proportion of patients (n = 15) showed spontaneous remission of disease, whereas five patients showed no spontaneous remission and six patients were treated with corticosteroids over the 2-year period of study. At the time of diagnosis, both plasma MCP-1 and MIP-1alpha levels in patients with active sarcoidosis were significantly higher than in the normal controls. The levels of these cytokines in patients with extrathoracic disease were compatible with those in patients without extrathoracic disease. A longitudinal evaluation of pl...Continue Reading

References

Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S Ylä-HerttualaD Steinberg
Mar 1, 1990·Immunology Today·E J Leonard, T Yoshimura
Jul 1, 1989·The American Review of Respiratory Disease·J Müller-QuernheimR Ferlinz
May 1, 1995·Journal of Leukocyte Biology·R E SmithS L Kunkel
May 1, 1994·Immunology Today·E M Fireman, M R Topilsky
Mar 1, 1994·Immunology Today·M Baggiolini, C A Dahinden
Jun 1, 1993·The American Review of Respiratory Disease·O P Sharma

❮ Previous
Next ❯

Citations

Mar 11, 2003·American Journal of Respiratory and Critical Care Medicine·Agata GibejovaMartin Petrek
Feb 18, 2003·Journal of Internal Medicine·M W Ziegenhagen, J Müller-Quernheim
Nov 25, 2003·Clinical and Experimental Immunology·A A KirkaldyD N J Lockwood
Jun 9, 2020·Experimental and Therapeutic Medicine·Alexandra ChiraDan Lucian Dumitrascu
Jul 27, 2005·Respiratory Research·Argyris TzouvelekisDemosthenes Bouros
Jul 10, 2014·International Journal of Immunopathology and Pharmacology·A BarczykE Sozańska
Apr 22, 2011·Clinical and Vaccine Immunology : CVI·Matthew J LozaRobert P Baughman
Dec 16, 2000·Allergy·G SemenzatoC Agostini
Jan 27, 2000·Current Opinion in Rheumatology·C AgostiniG Semenzato
Nov 5, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Agnieszka JazwaJozef Dulak
Jul 8, 2003·The Journal of Pathology·Katsunori JinnouchiMotohiro Takeya
Mar 23, 2000·The Journal of Pathology·W I de BoerP S Hiemstra
Mar 4, 2008·Clinical Genetics·G SmithS Prystowsky
Oct 7, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Subbiah RajasekaranKurt Ming-Chao Lin
Jul 27, 2001·Clinical and Experimental Immunology·K FuseY Aizawa
Jun 24, 1999·Cytokine & Growth Factor Reviews·E Van CoillieG Opdenakker
Apr 28, 2004·Biomaterials·D R HaynesH Zreiqat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.